Related Blog Entries

• Pfizer settles Bextra, Celebrex personal injury lawsuits
• Merck extends registration deadline in settlement for former users of Vioxx
• Study finds aspirin-resistant patients more prone to suffer heart attack, stroke
• Family hits GlaxoSmithKline with Avandia wrongful death lawsuit
• JAMA study also says Avandia causes heart attack
• First federal Vioxx trial scheduled
• Celebrex label revised yet again
• Judge rules health plans can sue over Vioxx prescription costs
• Ortho Evra linked to strokes and blood clots
• Deaths from Ortho Evra patch
• Ortho-McNeil facing seven product-liability suits
• Texas sues Merck over Vioxx
• Merck sought combo drug to lessen Vioxx risk
• Merck pressured doctors to refrain from discussing Vioxx safety concerns
• Ephedra Dietary Supplement Removed from Market
• COX-2 Drugs May Suppress Immune Function
• Merck allots $4.85 billion to settle Vioxx lawsuits
• Celebrex 3.6 times more likely to cause heart attack in Alzheimer’s patients
• Researchers can’t explain link between Pfizer’s torcetrapib and heart attacks, death
• Trasylol pulled from U.S. market
• FDA receives more testimony against Trasylol
• Ortho suit filed in embolism case
• Ortho Evra makers sued over blood clots
• Ortho Evra label updated for risk of clots
• New Study criticizes Ortho patch
• Lawsuit filed against Ortho-McNeil on behalf of woman who suffered pulmonary embolism while on Ortho Evra patch
• Johnson & Johnson Faces Thousands of Ortho Evra Lawsuits
• FDA Updates Labeling for Ortho Evra Contraceptive Patch
• Blood clots spark Missouri lawsuits
• 43-women file Ortho Evra patch lawsuits after serious health problems
• Medicare Continues to Deny Reimbursement for Anemia Drugs
• Scientists: Why Vioxx caused heart problems
• Eli Lilly to seek approval for experimental heart drug Prasugrel
• Death of heart bypass surgery patient raised questions about Bayer’s Trasylol
• Fed panel wants stricter ADHD drug labels
• Iowa man sues Bextra manufacturer over his stroke
• Pfizer agrees to suspend Celebrex advertising